Christine Malboeuf

Title: Christine Malboeuf: Innovator in Vaccine Development

Introduction

Christine Malboeuf is a prominent inventor based in Sharon, MA (US). She has made significant contributions to the field of immunology, particularly in the development of innovative vaccine technologies. Her work focuses on enhancing immune responses to infectious diseases and tumors.

Latest Patents

Christine holds a patent for a "Combined human papillomavirus VLP/gene delivery system and use thereof as a vaccine for prophylaxis and immunotherapy of infectious diseases and tumors." This invention relates to compositions that contain a chimeric papillomavirus virus-like particle (VLP) in combination with a DNA molecule encoding a protein or polypeptide epitope. The chimeric papillomavirus VLP is assembled from an L1 protein or polypeptide and a chimeric protein or polypeptide containing at least a portion of the L2 protein and a protein or polypeptide including an immunogenic epitope. The composition is useful for inducing an enhanced immune response against a pathogen or a tumor. Christine has 1 patent to her name.

Career Highlights

Christine is affiliated with the University of Rochester, where she continues her research and development efforts. Her work has been instrumental in advancing the understanding of vaccine mechanisms and their applications in disease prevention.

Collaborations

Christine has collaborated with notable colleagues, including Young-Eun Ellen Lee and Robert C. Rose. These partnerships have contributed to the success of her research initiatives and the development of her patented technologies.

Conclusion

Christine Malboeuf is a dedicated inventor whose work in vaccine development is paving the way for innovative solutions in immunotherapy. Her contributions are vital in the ongoing fight against infectious diseases and cancer.